Literature DB >> 30085025

Relation of regional myocardial structure and function in hypertrophic cardiomyopathy and amyloidois: a combined two-dimensional speckle tracking and cardiovascular magnetic resonance analysis.

Efstathios D Pagourelias1,2, Oana Mirea1,3, Georgios Vovas4, Jürgen Duchenne1, Blazej Michalski1, Johan Van Cleemput1, Jan Bogaert4, Vasilios P Vassilikos2, Jens-Uwe Voigt1.   

Abstract

AIMS: We aimed at investigating the relationship between segmental morphology [wall thickness (WT) and WT location (LT: base-mid-apex)], loading conditions and underlying pathological substrate [histology (H), hypertrophy vs. infiltration] with segmental longitudinal (SLS) and circumferential (SCS) strain in a group of patients with hypertrophic cardiomyopathy (HCM) and cardiac amyloidosis (CA). METHODS AND
RESULTS: We included 30 patients with biopsy-proven CA (65.4 ± 10.7 years, 66% male, 76.7% AL type) and 50 patients with HCM matched for maximum WT (60 ± 16 years, 80% male). SLS and SCS were assessed with speckle-tracking echocardiography in an 18-segment model of left ventricle, while morphological parameters were measured in short-axis cardiovascular magnetic resonance cine loops which corresponded with echo segments. In total, 1440 segments were evaluated of which 198 (36.7%) in CA and 252 (28%) in HCM had WT >12 mm (maximum WT 18.1 ± 3.7 mm in CA vs. 18.6 ± 4.1 in HCM, P = 0.59). SLS showed association with WT [beta 0.49, 95% confidence interval (CI) 0.37-0.6; P < 0.0005], LT and H (P < 0.0005 for both), with CA segments demonstrating 5.94% more impaired SLS compared with HCM segments with the same WT and LT. On the other hand, there was no linear association between SCS and WT, with SCS being dependent on LT, H (P < 0.0005) and preload (P < 0.002).
CONCLUSION: Our study indicates that regional myocardial mechanics are differentially influenced by local morphological parameters. While SLS is dominated by WT, SCS is more determined by LT and H. These findings may have an important role in diagnosis and prognosis of patients with thickened hearts. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2018. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  amyloidosis ; hypertrophic cardiomyopathy ; myocardial thickness ; segmental deformation ; strain

Mesh:

Year:  2019        PMID: 30085025     DOI: 10.1093/ehjci/jey107

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  5 in total

Review 1.  Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging.

Authors:  Georgios M Alexandridis; Efstathios D Pagourelias; Nikolaos Fragakis; Maria Kyriazi; Efthymia Vargiami; Dimitrios Zafeiriou; Vassilios P Vassilikos
Journal:  Heart Fail Rev       Date:  2022-07-20       Impact factor: 4.654

Review 2.  Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessment.

Authors:  Efstathios D Pagourelias; Georgios M Alexandridis; Vassilios P Vassilikos
Journal:  Heart Fail Rev       Date:  2021-05-15       Impact factor: 4.214

3.  Characterizing cardiac involvement in amyloidosis using cardiovascular magnetic resonance diffusion tensor imaging.

Authors:  Alexander Gotschy; Constantin von Deuster; Robbert J H van Gorkum; Mareike Gastl; Ella Vintschger; Rahel Schwotzer; Andreas J Flammer; Robert Manka; Christian T Stoeck; Sebastian Kozerke
Journal:  J Cardiovasc Magn Reson       Date:  2019-09-05       Impact factor: 5.364

Review 4.  Advances in the Treatment of Cardiac Amyloidosis.

Authors:  Ariane Vieira Scarlatelli Macedo; Pedro Vellosa Schwartzmann; Breno Moreno de Gusmão; Marcelo Dantas Tavares de Melo; Otávio Rizzi Coelho-Filho
Journal:  Curr Treat Options Oncol       Date:  2020-04-23

5.  Distinguishing Cardiac Amyloidosis and Hypertrophic Cardiomyopathy by Thickness and Myocardial Deformation of the Right Ventricle.

Authors:  Hui Liu; Peng Bai; Hua-Yan Xu; Zhen-Lin Li; Chun-Chao Xia; Xiao-Yue Zhou; Liang-Geng Gong; Ying-Kun Guo
Journal:  Cardiol Res Pract       Date:  2022-02-01       Impact factor: 1.866

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.